Pfizer is currently making the case for approval of its rheumatoid arthritis pill to the FDA Advisory Panel, reports CNBC's Seema Mody.
Related Links:
Business & financial news headlines from msnbc.com
Top of page
shuttle discovery biggest loser bonnie raitt internal revenue service intc ipad mini nfl schedule 2012
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.